We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
-0.52%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$82.9B
AUM Growth
-$1.95B
(-2.3%)
Cap. Flow
-$950M
Cap. Flow
% of AUM
-1.15%
Top 10 Holdings %
Top 10 Hldgs %
17.78%
Holding
800
New
57
Increased
242
Reduced
371
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$704M |
| 2 |
Howmet Aerospace
HWM
|
+$410M |
| 3 |
Nutrien
NTR
|
+$410M |
| 4 |
American Express
AXP
|
+$381M |
| 5 |
Stellantis
STLA
|
+$351M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$674M |
| 2 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$367M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$365M |
| 4 |
Sanofi
SNY
|
+$364M |
| 5 |
SHPG
Shire pic
SHPG
|
+$363M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 29.69% |
| 2 | Technology | 15.63% |
| 3 | Industrials | 12.69% |
| 4 | Healthcare | 11.72% |
| 5 | Energy | 9.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
CRH
CRH
$63.6B
| $254M | 0.31% |
7,461,449
+5,865,963
| +368% | +$208M |
|
102
FMC
FMC
$1.33B
| $250M | 0.3% |
3,767,001
+39,475
| +1% | +$2.94M |
|
103
Marvell Technology
MRVL
$217B
| $250M | 0.3% |
11,900,999
-718,466
| -6% | -$16.4M |
|
|
WCC
104
WESCO International
WCC
$17.1B
| $250M | 0.3% |
4,021,288
-2,669
| -0.1% | -$172K |
|
105
Textron
TXT
$14.2B
| $244M | 0.29% |
4,142,659
+193,786
| +5% | +$11.4M |
|
106
Dover
DOV
$27.2B
| $240M | 0.29% |
+3,020,314
| New | +$248M |
|
107
Avnet
AVT
$7.51B
| $238M | 0.29% |
5,691,279
+5,505,045
| +2,956% | +$233M |
|
108
Navient
NAVI
$873M
| $234M | 0.28% |
17,837,919
+999,807
| +6% | +$13.6M |
|
109
Medtronic
MDT
$115B
| $230M | 0.28% |
2,870,229
+59,530
| +2% | +$4.91M |
|
110
SL Green Realty
SLG
$4.1B
| $226M | 0.27% |
2,412,246
+53,865
| +2% | +$5.05M |
|
111
PACCAR
PCAR
$66.6B
| $226M | 0.27% |
5,125,674
+1,081,650
| +27% | +$51.2M |
|
112
Methanex
MEOH
$4.51B
| $225M | 0.27% |
3,713,595
+28,442
| +0.8% | +$1.67M |
|
113
KLA
KLAC
$240B
| $225M | 0.27% |
20,639,020
-3,401,670
| -14% | -$37.9M |
|
114
Belden
BDC
$4.69B
| $222M | 0.27% |
3,224,135
+362,772
| +13% | +$27.9M |
|
115
Novartis
NVS
$294B
| $220M | 0.27% |
3,036,853
+979,728
| +48% | +$74.6M |
|
|
VMRK
116
Vivmark Residential
VMRK
$26.1B
| $220M | 0.27% |
3,568,769
+1,591,045
| +80% | +$94.4M |
|
|
PARA
117
DELISTED
Paramount Global Class B
PARA
| $219M | 0.26% |
4,256,386
-674,593
| -14% | -$37M |
|
118
PepsiCo
PEP
$191B
| $219M | 0.26% |
2,002,357
+4,787
| +0.2% | +$544K |
|
119
Parker-Hannifin
PH
$127B
| $217M | 0.26% |
1,266,759
+619,359
| +96% | +$117M |
|
|
RSPP
120
DELISTED
RSP Permian, Inc.
RSPP
| $216M | 0.26% |
4,603,036
-4,233,663
| -48% | -$167M |
|
121
Alliant Energy
LNT
$17.7B
| $215M | 0.26% |
5,267,800
-1,585,430
| -23% | -$62.5M |
|
122
Verizon
VZ
$205B
| $215M | 0.26% |
4,497,581
-3,488,894
| -44% | -$175M |
|
123
Nomad Foods
NOMD
$1.68B
| $209M | 0.25% |
13,249,920
-225,567
| -2% | -$3.73M |
|
124
Bread Financial
BFH
$4.15B
| $207M | 0.25% |
1,221,310
+586,792
| +92% | +$115M |
|
125
Qorvo
QRVO
$8.49B
| $204M | 0.25% |
2,894,223
+25,013
| +0.9% | +$1.88M |
|
Similar funds
Boston Partners's Q1 2018 Portfolio in Review
As of Q1 2018, Boston Partners held 800 positions worth $82.9B, down 2.3% from $84.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Boston Partners's Q1 2018 filing shows 57 new, 242 increased, 371 reduced and 71 closed positions. Its largest new stake was Nutrien: 8,190,940 shares worth $387M. The largest sale was Apple, an estimated $674M.
By sector, the portfolio is most concentrated in Financials at 30% of assets, up from 29% a quarter earlier, followed by Technology and Industrials.
- Boston Partners's largest Q1 2018 buy was Nutrien: 8,190,940 shares worth $387M.
- Boston Partners added most to Johnson & Johnson in Q1 2018, an estimated $704M increase.
- Boston Partners's biggest Q1 2018 reduction was Apple, cutting an estimated $674M.
- Boston Partners fully exited Sanofi in Q1 2018, selling an estimated $364M.
- Boston Partners's ten largest holdings make up 18% of its $82.9B portfolio in Q1 2018.
- Boston Partners opened 57 new positions and closed 71 in Q1 2018.
- Boston Partners's portfolio value fell 2.3% quarter-over-quarter to $82.9B.
Based on Boston Partners's 13F filing for Q1 2018, filed 4 May 2018.